151 related articles for article (PubMed ID: 36178608)
21. Elevated Levels of Toxic Bile Acids in Serum of Cystic Fibrosis Patients with
Tabori H; Schneider J; Lüth S; Zagoya C; Barucha A; Lehmann T; Kauf E; Barth A; Mainz JG
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293293
[TBL] [Abstract][Full Text] [Related]
22. Cystic fibrosis transmembrane conductance regulator (CFTR) gene mutations in pancreatitis.
Ooi CY; Durie PR
J Cyst Fibros; 2012 Sep; 11(5):355-62. PubMed ID: 22658665
[TBL] [Abstract][Full Text] [Related]
23. Effects of gender and age at diagnosis on disease progression in long-term survivors of cystic fibrosis.
Nick JA; Chacon CS; Brayshaw SJ; Jones MC; Barboa CM; St Clair CG; Young RL; Nichols DP; Janssen JS; Huitt GA; Iseman MD; Daley CL; Taylor-Cousar JL; Accurso FJ; Saavedra MT; Sontag MK
Am J Respir Crit Care Med; 2010 Sep; 182(5):614-26. PubMed ID: 20448091
[TBL] [Abstract][Full Text] [Related]
24. Clinical and genetic risk factors for cystic fibrosis-related liver disease.
Wilschanski M; Rivlin J; Cohen S; Augarten A; Blau H; Aviram M; Bentur L; Springer C; Vila Y; Branski D; Kerem B; Kerem E
Pediatrics; 1999 Jan; 103(1):52-7. PubMed ID: 9917439
[TBL] [Abstract][Full Text] [Related]
25. Changing paradigms in the treatment of gastrointestinal complications of cystic fibrosis in the era of cystic fibrosis transmembrane conductance regulator modulators.
Konrad J; Eber E; Stadlbauer V
Paediatr Respir Rev; 2022 Jun; 42():9-16. PubMed ID: 33485777
[TBL] [Abstract][Full Text] [Related]
26. Urinary stone disease prevalence and associations in cystic fibrosis.
Wright JF; Craig WY; Lucas FL; Goldfarb DS; Zuckerman JB; Taylor EN
Urolithiasis; 2021 Oct; 49(5):415-423. PubMed ID: 33547925
[TBL] [Abstract][Full Text] [Related]
27. Risk factors for cystic fibrosis arthropathy: Data from the German cystic fibrosis registry.
Grehn C; Dittrich AM; Wosniok J; Holz F; Hafkemeyer S; Naehrlich L; Schwarz C;
J Cyst Fibros; 2021 Nov; 20(6):e87-e92. PubMed ID: 34034985
[TBL] [Abstract][Full Text] [Related]
28. Forskolin-induced organoid swelling is associated with long-term cystic fibrosis disease progression.
Muilwijk D; de Poel E; van Mourik P; Suen SWF; Vonk AM; Brunsveld JE; Kruisselbrink E; Oppelaar H; Hagemeijer MC; Berkers G; de Winter-de Groot KM; Heida-Michel S; Jans SR; van Panhuis H; van der Eerden MM; van der Meer R; Roukema J; Dompeling E; Weersink EJM; Koppelman GH; Vries R; Zomer-van Ommen DD; Eijkemans MJC; van der Ent CK; Beekman JM
Eur Respir J; 2022 Aug; 60(2):. PubMed ID: 35086832
[TBL] [Abstract][Full Text] [Related]
29. Malnutrition in adults with cystic fibrosis.
Dray X; Kanaan R; Bienvenu T; Desmazes-Dufeu N; Dusser D; Marteau P; Hubert D
Eur J Clin Nutr; 2005 Jan; 59(1):152-4. PubMed ID: 15367921
[TBL] [Abstract][Full Text] [Related]
30. V232D mutation in patients with cystic fibrosis: Not so rare, not so mild.
Fernández-Lorenzo AE; Moreno-Álvarez A; Colon-Mejeras C; Barros-Angueira F; Solar-Boga A; Sirvent-Gómez J; Couce ML; Leis R
Medicine (Baltimore); 2018 Jul; 97(28):e11397. PubMed ID: 29995784
[TBL] [Abstract][Full Text] [Related]
31. Modeling cystic fibrosis disease progression in patients with the rare CFTR mutation P67L.
MacKenzie IER; Paquette V; Gosse F; George S; Chappe F; Chappe V
J Cyst Fibros; 2017 May; 16(3):335-341. PubMed ID: 28392015
[TBL] [Abstract][Full Text] [Related]
32. [Ageing with cystic fibrosis: Classical and emerging comorbidities in adults with cystic fibrosis].
Regard L; Lafoeste H; Martin C; Chassagnon G; Burgel PR
Rev Pneumol Clin; 2018 Oct; 74(5):279-291. PubMed ID: 30316653
[TBL] [Abstract][Full Text] [Related]
33. Prevalence of dyslipidemia in adults with cystic fibrosis.
Rhodes B; Nash EF; Tullis E; Pencharz PB; Brotherwood M; Dupuis A; Stephenson A
J Cyst Fibros; 2010 Jan; 9(1):24-8. PubMed ID: 19875344
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal Trends in Real-World Outcomes after Initiation of Ivacaftor. A Cohort Study from the Cystic Fibrosis Registry of Ireland.
Kirwan L; Fletcher G; Harrington M; Jeleniewska P; Zhou S; Casserly B; Gallagher CG; Greally P; Gunaratnam C; Herzig M; Linnane B; McElvaney NG; McKone EF; McNally P; Mullane D; Ní Chróinín M; O'Mahony M; Plant BJ; Jackson AD
Ann Am Thorac Soc; 2019 Feb; 16(2):209-216. PubMed ID: 30427731
[TBL] [Abstract][Full Text] [Related]
35. Clinical expression of cystic fibrosis in a large cohort of Italian siblings.
Terlizzi V; Lucarelli M; Salvatore D; Angioni A; Bisogno A; Braggion C; Buzzetti R; Carnovale V; Casciaro R; Castaldo G; Cirilli N; Collura M; Colombo C; Di Lullo AM; Elce A; Lucidi V; Madarena E; Padoan R; Quattrucci S; Raia V; Seia M; Termini L; Zarrilli F
BMC Pulm Med; 2018 Dec; 18(1):196. PubMed ID: 30577776
[TBL] [Abstract][Full Text] [Related]
36. Genetic modifiers play a substantial role in diabetes complicating cystic fibrosis.
Blackman SM; Hsu S; Vanscoy LL; Collaco JM; Ritter SE; Naughton K; Cutting GR
J Clin Endocrinol Metab; 2009 Apr; 94(4):1302-9. PubMed ID: 19126627
[TBL] [Abstract][Full Text] [Related]
37. Comparison of radiographic and clinical characteristics of low-risk and high-risk cystic fibrosis genotypes.
Ferril GR; Nick JA; Getz AE; Barham HP; Saavedra MT; Taylor-Cousar JL; Nichols DP; Curran-Everett D; Kingdom TT; Ramakrishnan VR
Int Forum Allergy Rhinol; 2014 Nov; 4(11):915-20. PubMed ID: 25224556
[TBL] [Abstract][Full Text] [Related]
38. Factors associated with FEV1 decline in cystic fibrosis: analysis of the ECFS patient registry.
Kerem E; Viviani L; Zolin A; MacNeill S; Hatziagorou E; Ellemunter H; Drevinek P; Gulmans V; Krivec U; Olesen H;
Eur Respir J; 2014 Jan; 43(1):125-33. PubMed ID: 23598952
[TBL] [Abstract][Full Text] [Related]
39. Disease burden in people with cystic fibrosis heterozygous for F508del and a minimal function mutation.
Sawicki GS; Van Brunt K; Booth J; Bailey E; Millar SJ; Konstan MW; Flume PA
J Cyst Fibros; 2022 Jan; 21(1):96-103. PubMed ID: 34289939
[TBL] [Abstract][Full Text] [Related]
40. Early life growth trajectories in cystic fibrosis are associated with lung function at age six.
Psoter KJ; Dickinson KM; Riekert KA; Collaco JM
J Cyst Fibros; 2023 May; 22(3):395-401. PubMed ID: 36858852
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
